⌘K

Login Start Free

Home/Filings/4/0001628280-23-030129

4//SEC Filing

Warren Eric 4

Accession 0001628280-23-030129

CIK 0001434868other

View on SEC.gov Company Profile

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:32 PM ET

Size

18.0 KB

Accession

0001628280-23-030129

Insider Transaction Report

Form 4

Period: 2023-08-18

Esperion Therapeutics, Inc.ESPR

Chief Commercial Officer

Transactions

Sale
Common Stock
2023-08-18$1.41/sh−243$344→ 69,060 total

Footnotes (1)

[F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1

filerCIK 0001916048

Filing Metadata

Form type: 4
Filed: Aug 20, 8:00 PM ET
Accepted: Aug 21, 4:32 PM ET
Size: 18.0 KB

View on SEC.gov